Tredegar (NYSE:TG) Major Shareholder John Gottwald Sells 24,824 Shares of Stock

Tredegar Corporation (NYSE:TGGet Free Report) major shareholder John Gottwald sold 24,824 shares of the business’s stock in a transaction that occurred on Friday, January 23rd. The stock was sold at an average price of $8.52, for a total value of $211,500.48. Following the completion of the sale, the insider owned 640,992 shares of the company’s stock, valued at $5,461,251.84. The trade was a 3.73% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Tredegar Stock Performance

TG stock opened at $8.74 on Tuesday. The company has a market capitalization of $305.04 million, a PE ratio of -5.53 and a beta of 0.67. Tredegar Corporation has a one year low of $6.25 and a one year high of $9.43. The company’s 50 day moving average price is $7.74 and its two-hundred day moving average price is $7.84.

Tredegar (NYSE:TGGet Free Report) last announced its quarterly earnings data on Friday, November 7th. The basic materials company reported $0.26 earnings per share (EPS) for the quarter. The company had revenue of $194.94 million during the quarter. Tredegar had a negative net margin of 7.75% and a positive return on equity of 8.64%.

Institutional Investors Weigh In On Tredegar

Several institutional investors and hedge funds have recently bought and sold shares of the business. Russell Investments Group Ltd. increased its stake in shares of Tredegar by 531.0% during the third quarter. Russell Investments Group Ltd. now owns 3,376 shares of the basic materials company’s stock valued at $27,000 after buying an additional 2,841 shares during the period. BNP Paribas Financial Markets boosted its holdings in Tredegar by 53.2% in the third quarter. BNP Paribas Financial Markets now owns 5,273 shares of the basic materials company’s stock valued at $42,000 after acquiring an additional 1,830 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Tredegar by 225.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,889 shares of the basic materials company’s stock valued at $61,000 after purchasing an additional 4,771 shares during the period. Citadel Advisors LLC raised its holdings in Tredegar by 163.7% in the 3rd quarter. Citadel Advisors LLC now owns 11,850 shares of the basic materials company’s stock worth $95,000 after purchasing an additional 30,450 shares in the last quarter. Finally, Prelude Capital Management LLC purchased a new stake in shares of Tredegar in the 3rd quarter worth about $105,000. Hedge funds and other institutional investors own 79.24% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tredegar in a report on Wednesday, January 21st. Wall Street Zen raised Tredegar from a “hold” rating to a “strong-buy” rating in a research note on Saturday, November 15th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Get Our Latest Research Report on Tredegar

Tredegar Company Profile

(Get Free Report)

Tredegar Corporation is a diversified manufacturer specializing in high-performance plastic films and aluminum extrusions. Headquartered in Richmond, Virginia, the company operates through two primary segments—Films and Manufactured Products—serving a broad range of industries that include flexible packaging, medical devices, electronics, building and construction. Tredegar’s operations focus on delivering tailored solutions that meet demanding specifications for barrier properties, film strength and extrusion tolerances.

The Films segment produces a variety of polyolefin films, including cast and blown polyethylene, BOPP (biaxially oriented polypropylene), barrier films and specialty medical-grade films.

Further Reading

Insider Buying and Selling by Quarter for Tredegar (NYSE:TG)

Receive News & Ratings for Tredegar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tredegar and related companies with MarketBeat.com's FREE daily email newsletter.